45 results
8-K
EX-10.4
ELTX
Elicio Therapeutics, Inc.
12 Aug 24
Elicio Therapeutics Announces Closing of Private Placement of $20.0 Million Convertible Note
4:24pm
Guarantor or any collateral security or guarantee or right of offset held by the Purchasers for the payment of the Obligations, nor shall any Guarantor seek … security or guarantee therefor or right of offset with respect thereto, may, from time to time, in whole or in part, be renewed, extended, amended
424B5
ELTX
Elicio Therapeutics, Inc.
28 Jun 24
Prospectus supplement for primary offering
9:08pm
treaty) on any gain realized upon the sale or other taxable disposition of our common stock, common warrants or pre-funded warrants which may be offset
424B5
ELTX
Elicio Therapeutics, Inc.
27 Jun 24
Prospectus supplement for primary offering
4:42pm
upon the sale or other taxable disposition of our common stock, common warrants or pre-funded warrants which may be offset by U.S. source capital losses
8-K
EX-10.1
lob2psl2tx1fg nx
2 Feb 24
Departure of Directors or Certain Officers
8:51am
8-K/A
EX-99.2
0a5e52h8e
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K/A
EX-99.1
bo37k4c2s6j2stp
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.4
3uckp9yzxndt5iqfvc
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.5
w1de6374p
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
2aixu
28 Apr 23
Prospectus supplement
4:07pm